We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current LFCR market cap is 179.2M. The company's latest EPS is USD -3.2835 and P/E is -1.79.
| Quarter End | May 2022 | Aug 2022 | Nov 2022 | Feb 2023 | May 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 47.63M | 43.36M | 38.8M | -2.3M | 25.52M |
| Operating Income | -38.94M | -8.16M | -7.25M | -5.15M | -1.23M |
| Net Income | -36.66M | -12.06M | -11.74M | -40.19M | -35.57M |
| Year End 28 May 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 557.56M | 590.37M | 544.16M | 185.79M | 105.38M |
| Operating Income | 5.48M | -38.54M | -13.5M | -41.29M | -21.8M |
| Net Income | 411k | -38.19M | -32.67M | -97.43M | -99.56M |
| Quarter End | May 2022 | Aug 2022 | Nov 2022 | Feb 2023 | May 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 295.16M | 285.8M | 279.07M | 236.15M | 253.55M |
| Total Liabilities | 187.22M | 188.9M | 204.91M | 163.44M | 218.46M |
| Total Equity | 107.95M | 96.9M | 74.17M | 34.21M | -4.23M |
| Year End 28 May 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 519.09M | 541.31M | 502.92M | 295.16M | 253.55M |
| Total Liabilities | 248.95M | 310.27M | 300.14M | 187.22M | 218.46M |
| Total Equity | 270.14M | 231.04M | 202.78M | 107.95M | -4.23M |
| Quarter End | May 2022 | Aug 2022 | Nov 2022 | Feb 2023 | May 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -24.3M | -1.53M | -4.48M | -17.17M | -17.44M |
| Investing | 81.77M | 206k | -3.05M | 3.35M | -4.81M |
| Financing | -57.02M | 3.91M | 12.72M | 15.13M | 39.7M |
| Year End 28 May 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 16.02M | -17.04M | 15.02M | -24.3M | -17.44M |
| Investing | -96.8M | -23.89M | -10.86M | 81.77M | -4.81M |
| Financing | 79.03M | 40.02M | -3.42M | -57.02M | 39.7M |
| Market Cap | 179.2M |
| Price to Earnings Ratio | -1.79 |
| Price to Sales Ratio | 1.69 |
| Price to Cash Ratio | 9.36 |
| Price to Book Ratio | 5.09 |
| Dividend Yield | - |
| Shares Outstanding | 30.32M |
| Average Volume (1 week) | 168.61k |
| Average Volume (1 Month) | 173.52k |
| 52 Week Change | -30.80% |
| 52 Week High | 11.455 |
| 52 Week Low | 4.50 |
| Spread (Intraday) | 0.74 (11.92%) |
| Company Name | Lifecore Biomedical Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.lifecore.com |
| Industry | plastics,resins,elastomers (2821) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
